← Back to Search

Sodium Bicarbonate Catheter Lock for Intestinal Failure

Phase 2

Recruiting

Research Sponsored by Riad Rahhal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 1 year

Awards & highlights

Study Summary

This trial will study how a daily "lock" of sodium bicarbonate in central venous catheters can reduce infection risk for children with intestinal failure.

Who is the study for?

This trial is for children under 18 with intestinal failure who need daily IV nutrition or hydration through a central venous catheter. They must have had at least one previous infection related to their catheter, confirmed by blood culture.Check my eligibility

What is being tested?

The study tests the use of an 8.4% sodium bicarbonate lock solution in the catheters of these children when not in use for feeding or hydration, aiming to reduce infections.See study design

What are the potential side effects?

Potential side effects may include irritation at the catheter site, changes in blood pH levels due to absorption of bicarbonate, and possible interactions with other medications.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of catheter related bloodstream infections

Trial Design

1Treatment groups

Experimental Treatment

Group I: BaselineExperimental Treatment1 Intervention

Patient on heparin locks when off venous nutrition

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Riad RahhalLead Sponsor

Media Library

Baseline Clinical Trial Eligibility Overview. Trial Name: NCT05813535 — Phase 2

Intestinal Failure Research Study Groups: Baseline

Intestinal Failure Clinical Trial 2023: Baseline Highlights & Side Effects. Trial Name: NCT05813535 — Phase 2

Baseline 2023 Treatment Timeline for Medical Study. Trial Name: NCT05813535 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the criteria for eligibility in this medical experiment?

"This medical trial is currently seeking 15 participants with intestinal failure between the ages of one year and eighteen."

Answered by AI

Has this remedy obtained approval from the FDA?

"Our staff at Power evaluates the safety of this intervention to be a 3 due to the Phase 3 trial status, implying that there is evidence confirming its efficacy as well multiple rounds of data supporting its security."

Answered by AI

What is the aggregate figure of participants recruited for this medical experiment?

"Affirmative. Clinicaltrials.gov displays that this medical research, which was originally posted on December 1st 2022, is actively seeking participants. At the moment, 15 individuals are required to be enrolled from a single location."

Answered by AI

Are octogenarians permitted to partake in this investigation?

"This clinical trial is available to patients aged 1-18, with 38 trials dedicated solely to minors and another 147 for individuals who are 65 or older."

Answered by AI

Is there opportunity to enroll in this research endeavor at present?

"This clinical trial is currently recruiting and has been since its initial posting on December 1st, 2022. The study was most recently updated on April 2nd 2023 according to records held by clinicaltrials.gov."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

8.4% Sodium Bicarbonate Locks in Intestinal Failure

Riad Rahhal 2022. "8.4% Sodium Bicarbonate Locks in Intestinal Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05813535.

All > Sepsis